00:00 Dave Briggs
It is now time for a few of right now’s trending tickers. We’re watching Residents Monetary, Merck, and Occidental Petroleum. First up, let’s examine in on Residents Monetary, growing its share buyback authorization to 1 and a half billion {dollars}. That is a rise of 1.2 billion {dollars} above the 300 million {dollars} at the moment remaining beneath the prior June 2024 authorization right here. You are looking at shares, they’re slumping with the broader markets proper now, now down by about 1.3%. However this can be a appreciable transfer, particularly simply what we’re seeing inside banks extra broadly right here in among the urge for food for the monetary sector proper now. What are you seeing in a few of these uh performs as a thematic strategy from traders?
00:53 Josh Schafer
Yeah, so, nicely, banks have really underperformed a lot of the yr. We have seen outflows. KBE uh is a kind of giant financial institution diversified financial institution ETFs uh that Citizen Monetary is a part of and it is down. So it is good to see the corporate shopping for again inventory. I I believe we will see extra uh makes use of of buyback inventory. We’re taking a look at corporations which have robust free money stream which have the flexibility to do this. And for people which can be searching for an ETF actual fast, VFlow, uh Victory Shares free money stream ETF, corporations which have that robust functionality to purchase again inventory.
01:37 Dave Briggs
Nice context there. Additionally, we’re monitoring this title on the day. Merk, getting FDA approval for the usage of Keytruda to deal with head and neck most cancers. The drug had already been authorised to deal with numerous different cancers. They’re looking at Merk shares rising proper now by about three tenths of a p.c. And what’s noteworthy for lots of the biopharmaceutical corporations and biotechnology corporations is lots of them attempting to determine what’s the subsequent main aspect of their R&D pipeline that might add to its capacity to ship a few of each the margins, uh for traders which were searching for much more shareholder worth, but additionally simply searching for that subsequent large breakthrough. However Keytruda has largely been that for Merk, and that is why they’re searching for different sources whereas additionally leaning into the flexibility to prop up uh particularly by way of the approvals course of, among the the efficacious measures that they’ve seen thus far proper now.
02:57 Josh Schafer
Yeah, and it is nice to have the ability to see, you realize, healthcare tends to be a kind of traditionally defensive sectors. It additionally has underperformed uh for a lot of the yr. So it is nice to see a progress driver for a kind of giant cap corporations that you simply’d discover inside XLV. I’ll preserve throwing out ETF tickers. I am the ETF man. Mm-hmm.
03:21 Dave Briggs
Look, that is your that is your jam proper now. What’s the so what’s the ETF play inside healthcare that’s seemingly uh extra resilient at this juncture?
03:33 Josh Schafer
Yeah, I imply so XLV is the healthcare sector of the S&P 500. So you are going to get these giant cap corporations. Um biotechnology is extra progress oriented facet of it. So IBB would in case you needed to play that drug uh drug pipeline uh for particular person biotechnology corporations.
04:01 Dave Briggs
Lastly right here, let’s speak Occidental Petroleum. Occidental Petroleum getting a lift from surging oil costs. The Warren Buffett backed oil and fuel firm is certainly one of a number of power names climbing right now after Israel launched an assault on Iran’s nuclear services. It earlier right now was the highest trending ticker on the Yahoo Finance platform proper now. You are seeing it up about 3.4%. And this is likely one of the inexperienced areas of the market. We all know that that is the everyday exercise and response to when there’s battle that breaks out in one of the crucial oil and power and fuel wealthy parts of the world as nicely.
04:47 Josh Schafer
Proper. And so power is roughly 3% of the S&P 500. So it is a fairly small stake. Uh so when oil costs spike, that is often a foul factor for the remainder of the market, you realize, we talked about client sentiment earlier, however increased oil costs is a detrimental factor. So people that need to chubby their publicity to power, XLE is once more that S&P 500 one. I touched on AMLP, which is a extra steady uh uh MLP oriented product. That is for Molarian. That is a great way of uh having power publicity, however not essentially the identical degree of volatility. Proper. Yep.
05:31 Dave Briggs
Yeah, we have been speaking about, whilst you have been mentioning, the impacts that customers usually see when oil costs are decrease versus increased. Nicely, we have had a decrease protracted interval as nicely right here for just a little bit, and that enjoying into a few of what we had seen within the CPI launch earlier this week the place we noticed the gasoline index fall over the month, uh the power index decline by about 1% right here. You’ll be able to scan the QR code under to trace the very best and worst performing shares of the session with Yahoo Finance’s trending ticker web page.
